Biggest News Aggregation in the World
📰 Scott Struthers News

Page 3 - Scott Struthers News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Scott Struthers. Real-time updates on events, politics, business and more.

Sanders Morris Harris LLC Invests $336,000 in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

Sanders Morris Harris LLC acquired a new position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 18,600 shares of the company’s stock, valued at approximately $336,000. A number of other institutional investors and […]
Robertw Baird Richard Scott Struthers Marc Wilson Cantor Fitzgerald News Ratings For Crinetics Pharmaceuticals Daily Crinetics Pharmaceuticals Profile

Sanders Morris Harris LLC Acquires New Shares in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

Sanders Morris Harris LLC acquired a new stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) in the second quarter, according to its most recent filing with the SEC. The fund acquired 18,600 shares of the company’s stock, valued at approximately $336,000. Other hedge funds have also bought and sold shares of the company. Tower […]
Richard Scott Struthers Marc Wilson Robertw Baird Zurcher Kantonalbank Zurich Cantonalbank Cantor Fitzgerald News Ratings For Crinetics Pharmaceuticals Daily
Source: wkrb13.com

HC Wainwright Reaffirms "Buy" Rating for Crinetics Pharmaceuticals (NASDAQ:CRNX)

HC Wainwright reaffirmed their buy rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research note released on Monday, Benzinga reports. HC Wainwright currently has a $33.00 price objective on the stock. A number of other equities research analysts have also weighed in on the stock. Cantor Fitzgerald restated an overweight rating […]
Richard Scott Struthers Robertw Baird Marc Wilson Analyst Recommendations For Crinetics Pharmaceuticals Cantor Fitzgerald Crinetics Pharmaceuticals Stock Down
Source: wkrb13.com

Evercore ISI Increases Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $48.00

Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price objective boosted by Evercore ISI from $41.00 to $48.00 in a research note published on Monday morning, MarketBeat Ratings reports. They currently have an outperform rating on the stock. CRNX has been the topic of a number of other research reports. Cantor Fitzgerald reaffirmed an overweight […]
Marc Wilson Richard Scott Struthers Robertw Baird Blackrock Inc Crinetics Pharmaceuticals Inc Crinetics Pharmaceuticals Price Performance

Crinetics Pharmaceuticals' (CRNX) Buy Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research report report published on Monday, Benzinga reports. The firm currently has a $33.00 price target on the stock. Other equities analysts have also recently issued research reports about the stock. JMP Securities cut their price objective on […]
New Zealand General New Zealand Robertw Baird Marc Wilson Richard Scott Struthers Crinetics Pharmaceuticals

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Oppenheimer Boosts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $46.00

Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target upped by Oppenheimer from $40.00 to $46.00 in a report released on Monday morning, Marketbeat reports. The firm currently has an outperform rating on the stock. Other research analysts also recently issued reports about the company. HC Wainwright reissued a buy rating and issued a […]
New Zealand General New Zealand Marc Wilson Robertw Baird Richard Scott Struthers Blackrock Inc

Crinetics Pharmaceuticals (NASDAQ:CRNX) Shares Gap Up After Analyst Upgrade

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report)’s share price gapped up before the market opened on Tuesday after Evercore ISI raised their price target on the stock from $41.00 to $48.00. The stock had previously closed at $26.08, but opened at $27.00. Evercore ISI currently has an outperform rating on the stock. Crinetics Pharmaceuticals […]
Richard Scott Struthers Robertw Baird Marc Wilson Osaic Holdings Inc Bourgeon Capital Management Group One Trading
Source: wkrb13.com

Investors Purchase High Volume of Put Options on Crinetics Pharmaceuticals (NASDAQ:CRNX)

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw some unusual options trading activity on Tuesday. Stock traders bought 2,787 put options on the company. This represents an increase of 269% compared to the typical volume of 756 put options. Insider Activity In other news, CFO Marc Wilson sold 30,922 shares of the firm’s stock […]
New Zealand General New Zealand Marc Wilson Richard Scott Struthers News Ratings For Crinetics Pharmaceuticals Daily Crinetics Pharmaceuticals Inc
Source: wkrb13.com

Robert W. Baird Raises Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $45.00

Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) had its price target lifted by analysts at Robert W. Baird from $43.00 to $45.00 in a note issued to investors on Monday, FlyOnTheWall reports. Robert W. Baird’s target price points to a potential upside of 181.78% from the stock’s current price. A number of other analysts also […]
New Zealand General New Zealand Richard Scott Struthers Robertw Baird Marc Wilson News Ratings For Crinetics Pharmaceuticals Daily

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science